+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cellbag Bioreactor Chambers Market Outlook 2020-2030

  • PDF Icon

    Report

  • 208 Pages
  • January 2022
  • Region: Global
  • Research Nester Pvt. Ltd
  • ID: 5559861

Global Cellbag Bioreactor Chambers Market Analysis 2020-2030


The global cellbag bioreactor chambers market is anticipated to grow with a CAGR of 12.7% over the forecast period, i.e., 2021 - 2030. Factors such as the increasing trends of cell culture in the field of cellular and molecular biology, along with the growing research and developments in the field of healthcare are projected to drive the market growth. Moreover, factors such as the increasing prevalence of chronic diseases around the globe and the surge in use of stem cell therapies for the treatment of these chronic diseases, along with other diseases, such as for treating spinal cord injuries, Parkinson’s disease, diabetes, Alzheimer’s disease, and stroke among others are also anticipated to boost the market growth during the forecast period. The global cellbag bioreactor chambers market is estimated to garner a revenue of more than USD 5120 Million by the end of 2030, up from a revenue of near to USD 1550 Million in the year 2020.

The global cellbag bioreactor chambers market is segmented by numerous segments, which include segmentation by material, component, application, scale, end-user, and by region. By material, the market is segmented into ethylene vinyl acetate copolymer, low density polyethylene, thermoplastic elastomer, polyester, polypropylene, and others. The polypropylene segment, out of all the other segments, is anticipated to garner the largest revenue of around USD 1260 Million by the end of 2030, up from a revenue of close to USD 370 Million in the year 2020.

On the basis of regional analysis, the global cellbag bioreactor chambers market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America, amongst the market in all the other regions, is anticipated to garner the largest revenue of near to USD 2270 Million by the end of 2030, up from a revenue of about USD 720 Million in the year 2020.

Some of the prominent industry leaders in the global cellbag bioreactor chambers market that are included in our report are Thermo Fisher Scientific, Avantor, Inc., Global Life Sciences Solutions USA LLC (Cytiva), Sartorius AG, Pall Corporation, Celltainer Biotech BV, Adolf Kuhner AG, Merck KGaA, TERUMO BCT, INC., and others.

Table of Contents

1. Market Definition
1.1. Definition
1.2. Market Segmentation
2. Assumptions
3. Research Methodology
3.1. Research Process
3.2. Primary Research
3.3. Secondary Research
4. Executive Summary - Global Cellbag Bioreactor Chambers Market
5. Supply Chain Analysis
5.1. Analysis on the Key Component Suppliers
5.2. Analysis on the Manufacturers
5.3. Analysis on the End-Users
6. Market Dynamics
6.1. Market Drivers
6.2. Market Trends
7. Major Roadblocks for the Market Growth8. Key Opportunities9. Trade Outlook (Export-Import Analysis)10. Regulatory & Standards Landscape11. Impact of COVID-19 on the Global Cellbag Bioreactor Chambers Market12. Pricing Analysis13. Key Feature Analysis
14. Competitive Structure
14.1. Market Share Analysis, 2020
14.2. Competitive Benchmarking
14.3. Company Profiles
14.3.1. Thermo Fisher Scientific
14.3.2. Avantor, Inc.
14.3.3. Global Life Sciences Solutions USA LLC (Cytiva)
14.3.4. Sartorius AG
14.3.5. Pall Corporation
14.3.6. Celltainer Biotech BV
14.3.7. Adolf Kuhner AG
14.3.8. Merck KGaA
14.3.9. TERUMO BCT, INC.
15. Global Cellbag Bioreactor Chambers Market Overview 2020-2030
16. Global Cellbag Bioreactor Chambers Market - Segmentation Analysis 2020-2030
16.1. By Material
16.1.1. Ethylene vinyl acetate copolymer, 2020-2030F (USD million)
16.1.2. Low density polyethylene, 2020-2030F (USD million)
16.1.3. Thermoplastic elastomer, 2020-2030F (USD million)
16.1.4. Polyester, 2020-2030F (USD million)
16.1.5. Polypropylene, 2020-2030F (USD million)
16.1.6. Others, 2020-2030F (USD million)
16.2. By Component
16.2.1. Bioclear films, 2020-2030F (USD million)
16.2.2. Barbed ports, 2020-2030F (USD million)
16.2.3. MCP connectors, 2020-2030F (USD million)
16.2.4. Silicone tubing, 2020-2030F (USD million)
16.2.5. Internal perfusion filters, 2020-2030F (USD million)
16.2.6. Tubing adaptors, 2020-2030F (USD million)
16.2.7. Others, 2020-2030F (USD million)
16.3. By Application
16.3.1. Antibody production, 2020-2030F (USD million)
16.3.2. Virus Production, 2020-2030F (USD million)
16.3.3. Insect Cell Production, 2020-2030F (USD million)
16.3.4. Vaccines, 2020-2030F (USD million)
16.3.5. CGMP Production, 2020-2030F (USD million)
16.3.6. Others, 2020-2030F (USD million)
16.4. By Scale
16.4.1. < 50L, 2020-2030F (USD million)
16.4.2. 50 - 100L, 2020-2030F (USD million)
16.4.3. >100L, 2020-2030F (USD million)
16.5. By End- User
16.5.1. Pharmaceutical Companies, 2020-2030F (USD million)
16.5.2. Biopharmaceutical Companies, 2020-2030F (USD million)
16.5.3. Drug Discovery Companies, 2020-2030F (USD million)
16.5.4. Research Institutes, 2020-2030F (USD million)
16.6. By Region
16.6.1. North America
16.6.2. Europe
16.6.3. Asia Pacific
16.6.4. Latin America
16.6.5. Middle East & Africa
17. North America Cellbag Bioreactor Chambers Market Overview 2020-2030
17.1. North America Cellbag Bioreactor Chambers Market Segmentation Analysis 2020-2030
17.1.1. By Material
17.1.1.1. Ethylene vinyl acetate copolymer, 2020-2030F (USD million)
17.1.1.2. Low density polyethylene, 2020-2030F (USD million)
17.1.1.3. Thermoplastic elastomer, 2020-2030F (USD million)
17.1.1.4. Polyester, 2020-2030F (USD million)
17.1.1.5. Polypropylene, 2020-2030F (USD million)
17.1.1.6. Others, 2020-2030F (USD million)
17.1.2. By Component
17.1.2.1. Bioclear films, 2020-2030F (USD million)
17.1.2.2. Barbed ports, 2020-2030F (USD million)
17.1.2.3. MCP connectors, 2020-2030F (USD million)
17.1.2.4. Silicone tubing, 2020-2030F (USD million)
17.1.2.5. Internal perfusion filters, 2020-2030F (USD million)
17.1.2.6. Tubing adaptors, 2020-2030F (USD million)
17.1.2.7. Others, 2020-2030F (USD million)
17.1.3. By Application
17.1.3.1. Antibody production, 2020-2030F (USD million)
17.1.3.2. Virus Production, 2020-2030F (USD million)
17.1.3.3. Insect Cell Production, 2020-2030F (USD million)
17.1.3.4. Vaccines, 2020-2030F (USD million)
17.1.3.5. CGMP Production, 2020-2030F (USD million)
17.1.3.6. Others, 2020-2030F (USD million)
17.1.4. By Scale
17.1.4.1. < 50L, 2020-2030F (USD million)
17.1.4.2. 50 - 100L, 2020-2030F (USD million)
17.1.4.3. >100L, 2020-2030F (USD million)
17.1.5. By End- User
17.1.5.1. Pharmaceutical Companies, 2020-2030F (USD million)
17.1.5.2. Biopharmaceutical Companies, 2020-2030F (USD million)
17.1.5.3. Drug Discovery Companies, 2020-2030F (USD million)
17.1.5.4. Research Institutes, 2020-2030F (USD million)
17.1.6. By Country
17.1.6.1. United States
17.1.6.2. Canada
18. Europe Cellbag Bioreactor Chambers Market Overview 2020-2030
18.1. Europe Cellbag Bioreactor Chambers Market Segmentation Analysis 2020-2030
18.1.1. By Material
18.1.2. By Component
18.1.3. By Application
18.1.4. By Scale
18.1.5. By End-User
18.1.6. By Country
18.1.6.1. United Kingdom
18.1.6.2. Germany
18.1.6.3. France
18.1.6.4. Italy
18.1.6.5. Spain
18.1.6.6. Russia
18.1.6.7. Netherlands
18.1.6.8. Rest of Europe
19. Asia Pacific Cellbag Bioreactor Chambers Market Overview 2020-2030
19.1. Asia Pacific Cellbag Bioreactor Chambers Market Segmentation Analysis 2020-2030
19.1.1. By Material
19.1.2. By Component
19.1.3. By Application
19.1.4. By Scale
19.1.5. By End-User
19.1.6. By Country
19.1.6.1. China
19.1.6.2. Australia
19.1.6.3. Japan
19.1.6.4. Singapore
19.1.6.5. South Korea
19.1.6.6. India
19.1.6.7. Rest of Asia Pacific
20. Latin America Cellbag Bioreactor Chambers Market Overview 2020-2030
20.1. Latin America Cellbag Bioreactor Chambers Market Segmentation Analysis 2020-2030
20.1.1. By Material
20.1.2. By Component
20.1.3. By Application
20.1.4. By Scale
20.1.5. By End-User
20.1.6. By Country
20.1.6.1. Brazil
20.1.6.2. Mexico
20.1.6.3. Argentina
20.1.6.4. Rest of Latin America
21. Middle East & Africa Cellbag Bioreactor Chambers Market Overview 2020-2030
21.1. Middle East & Africa Cellbag Bioreactor Chambers Market Segmentation Analysis 2020-2030
21.1.1. By Material
21.1.2. By Component
21.1.3. By Application
21.1.4. By Scale
21.1.5. By End-User
21.1.6. By Country
21.1.6.1. GCC
21.1.6.2. Israel
21.1.6.3. South Africa
21.1.6.4. Rest of Middle East & Africa

Companies Mentioned

  • Thermo Fisher Scientific
  • Avantor Inc.
  • Global Life Sciences Solutions USA LLC (Cytiva)
  • Sartorius AG
  • Pall Corporation
  • Celltainer Biotech BV
  • Adolf Kuhner AG
  • Merck KGaA
  • TERUMO BCT Inc.